Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00194532 · ClinicalTrials.gov registry record · NA
Cefpodoxime vs Ciprofloxacin for Acute Cystitis
A NA study of Urinary Tract Infection, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 2
- Study locations
NCT00194532: Completed NA study of Urinary Tract Infection, sponsored by University of Washington.
NCT00194532 is a NA study of Urinary Tract Infection that has completed, run by University of Washington. The registered enrollment target is 300 participants, below the 646-participant average among 11 other Urinary Tract Infection trials with a reported enrollment target (54% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00194532, a NA study of Urinary Tract Infection, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 2
- Study locations
Study Summary
Urinary tract infection (UTI) is a very common problem in young healthy women, afflicting approximately one-half of women by their late 20s. One of the most common antibiotics used to treat UTIs is ciprofloxacin, usually for a total of three days. However, increasing resistance to this antibiotic has raised concerns about its overuse for cystitis and generated interest in alternative agents. An alternative antibiotic which is approved for use in UTIs is cefpodoxime. However, there are few studies evaluating the efficacy and tolerance of this compound when given in a 3-day regimen as is commonly used for treatment of UTI. The major purpose of this study is to assess the efficacy and tolerance of a 3-day regimen of cefpodoxime versus ciprofloxacin for treatment of acute uncomplicated cystitis.
Primary Outcome
Participants with clinical cure, i.e. free of urinary tract symptoms and requiring no further antibiotic treatment, to assess the efficacy of a 3-day regimen of cefpodoxime compared to ciprofloxacin
Conditions Studied
Interventions
- DRUG Ciprofloxacin
- DRUG Cefpodoxime
Study Locations (2)
Florida
- University of Miami Miller School of Medicine - Miami
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2005-06 |
| Est. Completion | 2009-02 |
| Phase | NA |
What the finished NCT00194532 record still lists
NCT00194532 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 646-participant average among 11 other Urinary Tract Infection trials with a reported enrollment target (54% lower).
The record links to 1 condition, with Urinary Tract Infection appearing as the primary indexed condition, and to 2 interventions - of which Ciprofloxacin is the first listed.
NCT00194532 reports a single indexed study location in Florida, Washington.
Frequently Asked Questions
What is clinical trial NCT00194532 about?
NCT00194532 is a clinical study titled "Cefpodoxime vs Ciprofloxacin for Acute Cystitis". Urinary tract infection (UTI) is a very common problem in young healthy women, afflicting approximately one-half of women by their late 20s. One of the most common antibiotics used to treat UTIs is ciprofloxacin, usually for a total of three days. However, increasing resistance to this antibiotic ha...
What is the current status of trial NCT00194532?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2005-06. Estimated completion is 2009-02.
What conditions does trial NCT00194532 study?
This clinical trial studies the following conditions: Urinary Tract Infection.
What interventions are being tested in trial NCT00194532?
The interventions under investigation include: Ciprofloxacin (DRUG), Cefpodoxime (DRUG).
Who is sponsoring clinical trial NCT00194532?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00194532 being conducted?
This trial has 2 study locations across Florida, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Tract Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00194532's enrollment target sits among peer trials
300 6th of 11 higher than 5 of 11 other Urinary Tract Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Tract Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Impact of Irrisept in Reducing Urinary Tract Infection During Urethral Catheter Removal.
RECRUITING · NA
-
Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion
RECRUITING · NA
-
Healthy.io Method Comparison & User Performance Study
COMPLETED · NA
-
ParentLink: Better and Safer Emergency Care for Children
COMPLETED
-
Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract Infections
COMPLETED · Phase 4
-
Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia